Evidence map›Paper›PMID 32368016›Full record

ArticlePatient preference and adherence2020

Defining Criteria for Guiding Cancer Patients to Find a Reputable Complementary Medicine Provider: Results of a Literature Review and a Consensus Procedure.

Alizé A Rogge, Isabel Baur, Gabriele Blettner, Ulrike Holtkamp, Markus Horneber, Patrick Jahn, Stefanie Joos, Silva Keberle, Anita Kettelgerdes, David Klemperer and 4 more

Abstract read
In one paragraph

Article in Patient preference and adherence, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. [Complementary nursing in oncology].Urologie (Heidelberg, Germany) · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alizé A RoggeInstitute for Social Medicine, Epidemiology, and Health Economics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Berlin, Germany.ORCID 0000-0001-5458-4222
Isabel BaurLegal Institute, Competence Center Medicine - Ethics - Law Helvetiae, University of Zurich, Zurich, Switzerland.
Gabriele BlettnerDeutsche Krebshilfe, INFONETZ KREBS, Bonn, Germany.ORCID 0000-0001-6688-9437
Ulrike HoltkampGerman Leukemia & Lymphoma Patients' Association, Bonn, Germany.
Markus HorneberDepartment of Internal Medicine, Division of Oncology and Hematology, Paracelsus Medical University, Klinikum Nuremberg, Nuremberg, Germany.ORCID 0000-0003-1011-1997
Patrick JahnDepartment for Nursing Science, Institute for Health Science, Medical Faculty, Eberhard Karls University Tübingen, Tübingen, Germany.
Stefanie JoosInstitute for General Practice and Interprofessional Health Care, University Clinic Tübingen, Tübingen 72076, Germany.
Silva KeberleEskamed AG, Basel, Switzerland.
Anita KettelgerdesTK - Techniker Krankenkasse, Hamburg, Germany.
David KlempererFaculty of Social and Health Sciences, Ostbayerische Technische Hochschule Regensburg, Regensburg., Germany.ORCID 0000-0003-0272-7425
Alfred LänglerGemeinschaftskrankenhaus Herdecke, Institute of Integrative Medicine, Witten/Herdecke University, Herdecke, Germany.ORCID 0000-0002-1443-8236
Petra VoißDepartment of Internal and Integrative Medicine, Evang. Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.ORCID 0000-0002-9005-0479
Joachim WeisDepartment of Self-Help Research, Comprehensive Cancer Center University Clinic Freiburg, Freiburg i.Br., Germany.
Claudia M WittInstitute for Social Medicine, Epidemiology, and Health Economics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Berlin, Germany.ORCID 0000-0002-5440-7805

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEven in cases of positive evidence for complementary medicine (CM) therapies, it is still difficult for cancer patients to identify reputable providers. The aim of this study was to develop and evaluate a criteria list to provide guidance to cancer patients seeking a reputable CM provider.

methodsThe design combined a literature review, an expert consensus procedure (n=15) and an assessment from three stakeholder perspectives (patients (n=18), CM providers (n=26) and oncology physicians (n=20)).

resultsA total of 30 existing CM criteria were extracted from the literature, and 12 more were added by the experts. The main challenge was to define criteria that could easily be applied by the patients. A final comprehensive list of 8 criteria guiding cancer patients to find a reputable CM provider was developed.

conclusionHealth professionals and cancer information services might find the criteria list helpful when aiming to strengthen patients' awareness of quality-related factors associated with CM providers. The criteria developed might be helpful when standards are established for quality assurance in CM in oncology.

Indexed as

complementary medicinehealthcare quality assuranceneoplasmspatient-centered carestandards

Identifiers

PMID32368016
PMCPMC7183350

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.